Elsevier Inc.

SHERPA: Unknown

People

  1. Saltz
    Saltz
  2. Ilson
    Ilson
  3. Kelsen
    Kelsen
  4. O'Reilly
    O'Reilly
  5. Kemeny
    Kemeny
  6. Wu
    Wu
  7. Abou-Alfa
    Abou-Alfa
  8. Epstein
    Epstein
  9. Crane
    Crane
  10. Shahrokni
    Shahrokni

Groups

  1. Department of Medicine (404)
  2. Gastrointestinal Oncology Service (404)
  3. Solid Tumor Oncology Division (404)
  4. Center for Pancreatic Cancer Research (171)
  5. Survivorship Research (106)
  6. Surgery (92)
  7. Epidemiology and Biostatistics (58)
  8. Radiation Oncology, Department of (51)
  9. Division of Subspecialty Medicine (48)
  10. Biostatistics Service (42)
Search Within
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (251)
  2. Meeting Abstract (109)
  3. Review (16)
  4. Book Section (10)
  5. Editorial (7)
  6. Conference Paper (6)
  7. Guidelines (3)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (404)
  2. Gastrointestinal Oncology Service (404)
  3. Solid Tumor Oncology Division (404)
  4. Center for Pancreatic Cancer Research (171)
  5. Survivorship Research (106)
  6. Surgery (92)

More Groups

People
  1. Leonard Saltz (73)
  2. David Ilson (57)
  3. Nancy Kemeny (57)
  4. David Kelsen (52)
  5. Eileen O'Reilly (48)
  6. Abraham Wu (37)

More People

Years
  1. 2025 (9)
  2. 2024 (22)
  3. 2023 (21)
  4. 2022 (22)
  5. 2021 (15)
  6. 2020 (23)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (64)
  2. European Journal of Cancer (50)
  3. Seminars in Oncology (38)
  4. Clinical Colorectal Cancer (34)
  5. Journal of Thoracic Oncology (24)
  6. Journal of Geriatric Oncology (23)

More Publications

Results (404)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Liver and bile duct cancer
    Book Section

    Abou-Alfa, G. K.; Jarnagin, W.; Lowery, M.; D'Angelica, M.; Brown, K.; Ludwig, E.; Covey, A.; Kemeny, N.; Goodman, K. A.; Shia, J.; more...
    In Niederhuber, J. E.; Armitage, J. O.; Doroshow, J. H.; Kastan, M. B.; Tepper, J. E. (Eds.) Abeloff's Clinical Oncology. 5th ed (2014)

    Fulltext@MSK | Save
  • Esophageal cancer: Treatment
    Journal Article

    Ku, G. Y.; Ilson, D. H.
    Reference Module in Biomedical Sciences (2014)

    Fulltext@MSK | Save
  • Phase I study of the selective BRAFV600 inhibitor encorafenib (LGX818) combined with cetuximab and with or without the α-specific PI3K inhibitor alpelisib (BYL719) in patients with advanced BRAF mutant colorectal cancer
    Meeting Abstract

    Tabernero, J.; van Geel, R.; Bendell, J. C.; Spreafico, A.; Schuler, M.; Yoshino, T.; Delord, J. P.; Yamada, Y.; Lolkema, M. P.; Fans, J. E.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Biomarker analysis in Phase 1b study of anti-cancer stem cell antibody Tarextumab (TAR) in combination with nab-paclitaxel and gemcitabine (Nab-P+Gem) demonstrates pharmacodynamic (PD) modulation of the Notch pathway in patients (pts) with untreated metastatic pancreatic cancer (mPC)
    Meeting Abstract

    Kapoun, A.; O'reilly, E.; Cohn, A.; Bendell, J. C.; Smith, L.; Strickler, J. H.; Gluck, W.; Liu, Y. W.; Wallace, B.; Tam, R.; more...
    European Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • Continued afatinib (A) with the addition of cetuximab (C) after progression on afatinib in patients with acquired resistance (AR) to gefitinib (G) or erlotinib (E)
    Meeting Abstract

    Horn, L.; Gettinger, S.; Camidge, R.; Smit, E.; Janjigian, Y.; Pao, W.; Schnell, D.; Wang, B.; Chand, V.; Groen, H.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • The initial report of local control on RTOG 0436: A phase 3 trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery
    Meeting Abstract

    Suntharalingam, M.; Winter, K.; Ilson, D.; Dicker, A. P.; Kachnic, L. A.; Konski, A. A.; Chakravarthy, B.; Anker, C. J.; Thakrar, H.; Horiba, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Chemotherapy and intensity modulated radiation therapy for locally advanced pancreatic cancer achieves prolonged survival
    Meeting Abstract

    Hajj, C.; Huguet, F.; Wu, A.; Shi, W.; Zhang, Z.; O'reilly, E.; Winston, C.; Reidy, D.; Ho, A.; Allen, P.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Capecitabine plus mitomycin in patients undergoing definitive chemoradiation for anal squamous cell carcinoma
    Meeting Abstract

    Goodman, K. A.; Rothenstein, D.; Lajhem, C.; Wu, A.; Cercek, A.; Saltz, L. B.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Prognostic significance of FDG-PET metrics in esophageal squamous cell carcinoma
    Meeting Abstract

    Chhabra, A. M.; Ong, L. T.; Kuk, D.; Ku, G.; Ilson, D.; Janjigian, Y. Y.; Wu, A.; Schoder, H.; Goodman, K. A.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save